Benchmark Candidates Against Venture DNA and Criteria
Cross-examine candidate deal terms and partner profiles against the core strategic objectives, valuation goals, and risk parameters defined in the venture DNA. Evaluate whether licensing accelerates or undermines long-term exit and M&A positioning. Verify alignment with overall corporate strategy, capital efficiency targets, and existing operational capabilities.
Completing this action alone ensures that any potential licensing agreement directly reinforces the long-term strategic trajectory of the venture. It prevents short-term cash generation from compromising core venture equity value or future acquisition readiness.
The founder must deliver a formal alignment assessment comparing each licensing opportunity against the strategic principles set out in the venture DNA. The document must explicitly state whether each prospective deal enhances or dilutes long-term venture valuation.
Five questions an expert would ask when reviewing your output
Use these to challenge assumptions, pressure-test your logic, and check the quality of this action's output in the context of the parent task and wider venture development.
- 1
In what ways does granting an exclusive licence to this partner constrain your future M&A valuation or acquirer pool?
- 2
How does this deal structure align with the primary value-creation milestones defined in your venture DNA?
- 3
What evidence demonstrates that licensing this IP yields a higher risk-adjusted return than direct market execution?
- 4
How do the geographic or sectoral boundaries of this licence protect your ability to raise future venture capital?
- 5
Where does this proposed commercial terms structure conflict with existing investor expectations or cap table covenants?